Insider Transactions in Q2 2025 at Neuro Pace Inc (NPCE)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 21
2025
|
Frank M Fischer |
BUY
Grant, award, or other acquisition
|
Direct |
2,281
+0.39%
|
$22,810
$10.41 P/Share
|
|
Jun 21
2025
|
Joseph Lacob |
BUY
Grant, award, or other acquisition
|
Direct |
1,080
+8.21%
|
$10,800
$10.41 P/Share
|
|
Jun 21
2025
|
Rakhi Kumar |
BUY
Grant, award, or other acquisition
|
Direct |
1,440
+8.45%
|
$14,400
$10.41 P/Share
|
|
Jun 21
2025
|
Uri Geiger |
BUY
Grant, award, or other acquisition
|
Direct |
1,140
+8.65%
|
$11,400
$10.41 P/Share
|
|
Jun 20
2025
|
Patrick F. Williams Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
51,850
+50.0%
|
-
|
|
Jun 03
2025
|
Martha Morrell CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,338
-1.53%
|
$17,394
$13.54 P/Share
|
|
Jun 03
2025
|
Rebecca Kuhn CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,337
-1.01%
|
$17,381
$13.54 P/Share
|
|
May 27
2025
|
Martha Morrell CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
357
-0.41%
|
$4,284
$12.66 P/Share
|
|
May 27
2025
|
Rebecca Kuhn CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
357
-0.27%
|
$4,284
$12.66 P/Share
|
|
May 27
2025
|
Joel Becker CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,126
-1.06%
|
$13,512
$12.66 P/Share
|
|
May 20
2025
|
Martha Morrell CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
3,051
-3.36%
|
$51,867
$17.99 P/Share
|
|
May 20
2025
|
Rebecca Kuhn CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
3,051
-2.24%
|
$51,867
$17.99 P/Share
|
|
May 14
2025
|
Orbimed Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
168,136
-2.49%
|
$2,522,040
$15.89 P/Share
|
|
Apr 22
2025
|
Rebecca Kuhn CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
237
-0.17%
|
$2,370
$10.94 P/Share
|
|
Apr 22
2025
|
Martha Morrell CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
237
-0.26%
|
$2,370
$10.94 P/Share
|